{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,25]],"date-time":"2026-08-25T07:20:10Z","timestamp":1787642410226,"version":"build-2736575974"},"reference-count":36,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,8,13]],"date-time":"2026-08-13T00:00:00Z","timestamp":1786579200000},"content-version":"vor","delay-in-days":12,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100001782","name":"University of Melbourne","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100001782","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Breast Cancer Res Treat"],"published-print":{"date-parts":[[2026,8]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Purpose<\/jats:title>\n                    <jats:p>The role of contrast-based imaging (CBI) at diagnosis in early breast cancer remains debated. More sensitive baseline staging may identify synchronous disease that would otherwise present as early ipsilateral or contralateral events. We examined whether CBI at diagnosis is associated with differences in early locoregional outcomes.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>A retrospective cohort study of women with early invasive breast cancer or ductal carcinoma in situ (DCIS). Patients were grouped according to whether they underwent CBI (CEM or MRI) at diagnosis. All underwent mammographic surveillance including contrast-enhanced mammography (CEM). Locoregional events from diagnosis to 30 June 2025 were identified and evaluated. Cox proportional hazards models to assess associations between CBI use and subsequent locoregional events were adjusted for age, calendar period, mammographic density (MD), and stage.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      Among 1,106 women (594 CBI, 512 non-CBI) diagnosed between April 2015 and June 2022, there were 60 locoregional events (39 invasive, 21 DCIS). Patients who underwent CBI had fewer subsequent locoregional events. After adjustment, CBI use at diagnosis was associated with significantly lower 5-year event rates among women with invasive cancer (adjusted HR 0.50, 95% CI 0.26\u20130.98,\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.043), particularly those with Luminal A\/B phenotypes, low MD, and with fewer contralateral events in invasive index cases (adjusted HR 0.19, 95% CI 0.05\u20130.71,\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.014). Features of subsequent events (including tumour grade, behaviour, and invasive size) were not found to differ between groups.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Inclusion of CBI in local staging of early breast cancer was associated with lower rates of locoregional events over five years. These findings support broader consideration of CBI use for local staging at diagnosis.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1007\/s10549-026-08049-6","type":"journal-article","created":{"date-parts":[[2026,8,13]],"date-time":"2026-08-13T12:46:30Z","timestamp":1786625190000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Fewer breast cancers during post-treatment surveillance among patients initially staged using contrast-based imaging"],"prefix":"10.1007","volume":"218","author":[{"given":"T. W. W.","family":"Yang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A. K.","family":"Rose","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Matheson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K.","family":"Elder","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"MacCallum","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Nickson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G. B.","family":"Mann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,8,13]]},"reference":[{"issue":"3","key":"8049_CR1","doi-asserted-by":"publisher","first-page":"520","DOI":"10.1148\/radiol.2019182947","volume":"292","author":"RM Mann","year":"2019","unstructured":"Mann RM, Cho N, Moy L, Breast MRI (2019) state of the art. Radiology 292(3):520\u2013536. https:\/\/doi.org\/10.1148\/radiol.2019182947","journal-title":"Radiology"},{"issue":"8","key":"8049_CR2","doi-asserted-by":"publisher","first-page":"1296","DOI":"10.1016\/j.ejca.2010.02.015","volume":"46","author":"F Sardanelli","year":"2010","unstructured":"Sardanelli F, Boetes C, Borisch B et al (2010) Magnetic resonance imaging of the breast: recommendations from the EUSOMA working group. Eur J Cancer 46(8):1296\u20131316. https:\/\/doi.org\/10.1016\/j.ejca.2010.02.015","journal-title":"Eur J Cancer"},{"issue":"19","key":"8049_CR3","doi-asserted-by":"publisher","first-page":"3248","DOI":"10.1200\/JCO.2007.15.2108","volume":"26","author":"N Houssami","year":"2008","unstructured":"Houssami N, Ciatto S, Macaskill P, Lord SJ, Warren RM et al (2008) Accuracy and Surgical Impact of Magnetic Resonance Imaging in Breast Cancer Staging: Systematic Review and Meta-Analysis in Detection of Multifocal and Multicentric Cancer. J Clin Oncol 26(19):3248\u20133258. https:\/\/doi.org\/10.1200\/JCO.2007.15.2108","journal-title":"J Clin Oncol"},{"issue":"9714","key":"8049_CR4","doi-asserted-by":"publisher","first-page":"563","DOI":"10.1016\/S0140-6736(09)62070-5","volume":"375","author":"L Turnbull","year":"2010","unstructured":"Turnbull L, Brown S, Harvey I, Olivier C, Drew P et al (2010) Comparative effectiveness of MRI in breast cancer (COMICE) trial: a randomised controlled trial. Lancet 375(9714):563\u2013571. https:\/\/doi.org\/10.1016\/S0140-6736(09)62070-5","journal-title":"Lancet"},{"issue":"6","key":"8049_CR5","doi-asserted-by":"publisher","first-page":"879","DOI":"10.1016\/j.ejca.2010.11.035","volume":"47","author":"NHGM Peters","year":"2011","unstructured":"Peters NHGM, van Esser S, van den Bosch MAAJ, Storm RK, Plaisier PW, the MONET study group (2011) Preoperative MRI and surgical management in patients with nonpalpable breast cancer: the MONET \u2013 randomised controlled trial. Eur J Cancer 47(6):879\u2013886. https:\/\/doi.org\/10.1016\/j.ejca.2010.11.035","journal-title":"Eur J Cancer"},{"issue":"7","key":"8049_CR6","doi-asserted-by":"publisher","first-page":"1685","DOI":"10.1007\/s00268-014-2605-0","volume":"38","author":"V Gonzalez","year":"2014","unstructured":"Gonzalez V, Sandelin K, Karlsson A, \u00c5berg W, L\u00f6fgren L et al (2014) Preoperative MRI of the breast (POMB) influences primary treatment in breast cancer: a prospective, randomized, multicenter study. World J Surg 38(7):1685\u20131693. https:\/\/doi.org\/10.1007\/s00268-014-2605-0","journal-title":"World J Surg"},{"issue":"4","key":"8049_CR7","doi-asserted-by":"publisher","first-page":"1112","DOI":"10.1177\/08465371231184769","volume":"74","author":"LA Eisen","year":"2023","unstructured":"Eisen LA, Kornecki A, Chartier C, Jalali S, Hodgson N et al (2023) Breast Magnetic Resonance Imaging for Preoperative Evaluation of Breast Cancer: A Systematic Review and Meta-Analysis. Can Assoc Radiol J 74(4):1112\u20131124. https:\/\/doi.org\/10.1177\/08465371231184769","journal-title":"Can Assoc Radiol J"},{"issue":"3","key":"8049_CR8","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1007\/s10549-023-06884-5","volume":"198","author":"BS Mota","year":"2023","unstructured":"Mota BS, Reis YN, de Barros N, Cardoso NP, Mota RMS et al (2023) Effects of preoperative magnetic resonance image on survival rates and surgical planning in breast cancer conservative surgery: randomized controlled trial (BREAST-MRI trial). Breast Cancer Res Treat 198(3):447\u2013461. https:\/\/doi.org\/10.1007\/s10549-023-06884-5","journal-title":"Breast Cancer Res Treat"},{"issue":"12","key":"8049_CR9","doi-asserted-by":"publisher","first-page":"8021","DOI":"10.1245\/s10434-024-15833-5","volume":"31","author":"A Mattar","year":"2024","unstructured":"Mattar A, Antonini M, Amorim A, Mateus EF, Bagnoli F et al (2024) PROMRIINE (PRe-operatory Magnetic Resonance Imaging is INEffective) Study: A Systematic Review and Meta-analysis of the Impact of Magnetic Resonance Imaging on Surgical Decisions and Clinical Outcomes in Women with Breast Cancer. Ann Surg Oncol 31(12):8021\u20138029. https:\/\/doi.org\/10.1245\/s10434-024-15833-5","journal-title":"Ann Surg Oncol"},{"issue":"1","key":"8049_CR10","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1007\/s00423-025-03691-y","volume":"410","author":"MK Banisi","year":"2025","unstructured":"Banisi MK, Ghadri H, Soltani B, Farshid A, Behnam B et al (2025) The effect of pre-operative MRI on the in-breast tumor recurrence rate of patients with breast cancer: a meta-analysis. Langenbecks Arch Surg 410(1):120. https:\/\/doi.org\/10.1007\/s00423-025-03691-y","journal-title":"Langenbecks Arch Surg"},{"issue":"1118","key":"8049_CR11","doi-asserted-by":"publisher","first-page":"20201046","DOI":"10.1259\/bjr.20201046","volume":"94","author":"R Sudhir","year":"2021","unstructured":"Sudhir R, Sannapareddy K, Potlapalli A, Krishnamurthy PB, Buddha S et al (2021) Diagnostic accuracy of contrast-enhanced digital mammography in breast cancer detection in comparison to tomosynthesis, synthetic 2D mammography and tomosynthesis combined with ultrasound in women with dense breast. Br J Radiol 94(1118):20201046. https:\/\/doi.org\/10.1259\/bjr.20201046","journal-title":"Br J Radiol"},{"issue":"1","key":"8049_CR12","doi-asserted-by":"publisher","first-page":"174","DOI":"10.7150\/jca.79747","volume":"14","author":"LMFH Neeter","year":"2023","unstructured":"Neeter LMFH, Robbe MMQ, van Nijnatten TJA, Jochelson MS, Raat HPJ et al (2023) Comparing the Diagnostic Performance of Contrast-Enhanced Mammography and Breast MRI: a Systematic Review and Meta-Analysis. J Cancer 14(1):174\u2013182. https:\/\/doi.org\/10.7150\/jca.79747","journal-title":"J Cancer"},{"issue":"1","key":"8049_CR13","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1148\/radiol.2021201948","volume":"299","author":"MS Jochelson","year":"2021","unstructured":"Jochelson MS, Lobbes MBI (2021) Contrast-enhanced Mammography: State of the Art. Radiology 299(1):36\u201348. https:\/\/doi.org\/10.1148\/radiol.2021201948","journal-title":"Radiology"},{"issue":"10","key":"8049_CR14","doi-asserted-by":"publisher","first-page":"6820","DOI":"10.1245\/s10434-024-15848-y","volume":"31","author":"C MacCallum","year":"2024","unstructured":"MacCallum C, Elder K, Nickson C, Ruecker K, Park A et al (2024) Contrast-Enhanced Mammography in Local Staging of Screen-Detected Breast Cancer. Ann Surg Oncol 31(10):6820\u20136830. https:\/\/doi.org\/10.1245\/s10434-024-15848-y","journal-title":"Ann Surg Oncol"},{"issue":"2","key":"8049_CR15","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1007\/s10549-024-07419-2","volume":"208","author":"J Matheson","year":"2024","unstructured":"Matheson J, Elder K, Nickson C, Park A, Mann GB et al (2024) Contrast-enhanced mammography for surveillance in women with a personal history of breast cancer. Breast Cancer Res Treat 208(2):293\u2013305. https:\/\/doi.org\/10.1007\/s10549-024-07419-2","journal-title":"Breast Cancer Res Treat"},{"key":"8049_CR16","doi-asserted-by":"publisher","unstructured":"Mann GB (2025 Aug) ASBrS Keynote Address: Reimagining Stage 1 Breast Cancer-Evolution of Breast Cancer Management over the Last 120 Years. Ann Surg Oncol 7. https:\/\/doi.org\/10.1245\/s10434-025-17849-x","DOI":"10.1245\/s10434-025-17849-x"},{"issue":"2","key":"8049_CR17","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1007\/s10549-023-06916-0","volume":"199","author":"K Elder","year":"2023","unstructured":"Elder K, Matheson J, Nickson C, Box G, Ellis J et al (2023) Contrast enhanced mammography in breast cancer surveillance. Breast Cancer Res Treat 199(2):221\u2013230. https:\/\/doi.org\/10.1007\/s10549-023-06916-0","journal-title":"Breast Cancer Res Treat"},{"issue":"16","key":"8049_CR18","doi-asserted-by":"publisher","first-page":"1233","DOI":"10.1056\/NEJMoa022152","volume":"347","author":"B Fisher","year":"2002","unstructured":"Fisher B, Anderson S, Bryant J, Margolese RG, Deutsch M et al (2002) Twenty-year follow-up of a randomized trial comparing total mastectomy, lumpectomy, and lumpectomy plus irradiation for the treatment of invasive breast cancer. N Engl J Med 347(16):1233\u20131241. https:\/\/doi.org\/10.1056\/NEJMoa022152","journal-title":"N Engl J Med"},{"issue":"3","key":"8049_CR19","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1016\/S1470-2045(14)71221-5","volume":"16","author":"IH Kunkler","year":"2015","unstructured":"Kunkler IH, Williams LJ, Jack WJ, Cameron DA, Dixon JM (2015) PRIME II investigators. Breast-conserving surgery with or without irradiation in women aged 65 years or older with early breast cancer (PRIME II): a randomised controlled trial. Lancet Oncol 16(3):266\u2013273. https:\/\/doi.org\/10.1016\/S1470-2045(14)71221-5","journal-title":"Lancet Oncol"},{"issue":"10","key":"8049_CR20","doi-asserted-by":"publisher","first-page":"971","DOI":"10.1056\/NEJMoa040587","volume":"351","author":"KS Hughes","year":"2004","unstructured":"Hughes KS, Schnaper LA, Berry D, Cirrincione C, McCormick B, Cancer and Leukemia Group B; Radiation Therapy Oncology Group; Eastern Cooperative Oncology Group et al (2004) Lumpectomy plus tamoxifen with or without irradiation in women 70 years of age or older with early breast cancer. N Engl J Med 351(10):971\u2013977. https:\/\/doi.org\/10.1056\/NEJMoa040587","journal-title":"N Engl J Med"},{"issue":"7","key":"8049_CR21","doi-asserted-by":"publisher","first-page":"1205","DOI":"10.1200\/JCO.2003.03.130","volume":"21","author":"A Wallgren","year":"2003","unstructured":"Wallgren A, Bonetti M, Gelber RD, Goldhirsch A, Castiglione-Gertsch M, International Breast Cancer Study Group Trials I through VII et al (2003) Risk factors for locoregional recurrence among breast cancer patients: results from International Breast Cancer Study Group Trials I through VII. J Clin Oncol 21(7):1205\u20131213. https:\/\/doi.org\/10.1200\/JCO.2003.03.130","journal-title":"J Clin Oncol"},{"issue":"3","key":"8049_CR22","doi-asserted-by":"publisher","first-page":"662","DOI":"10.1158\/1055-9965.EPI-04-0327","volume":"14","author":"EJ Aiello","year":"2005","unstructured":"Aiello EJ, Buist DS, White E, Porter PL (2005) Association between mammographic breast density and breast cancer tumor characteristics. Cancer Epidemiol Biomarkers Prev 14(3):662\u2013668. https:\/\/doi.org\/10.1158\/1055-9965.EPI-04-0327","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"issue":"4","key":"8049_CR23","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1186\/bcr2607","volume":"12","author":"EA Rakha","year":"2010","unstructured":"Rakha EA, Reis-Filho JS, Baehner F, Dabbs DJ, Decker T et al (2010) Breast cancer prognostic classification in the molecular era: the role of histological grade. Breast Cancer Res 12(4):207. https:\/\/doi.org\/10.1186\/bcr2607","journal-title":"Breast Cancer Res"},{"issue":"3","key":"8049_CR24","doi-asserted-by":"publisher","first-page":"831","DOI":"10.1007\/s10549-011-1891-6","volume":"133","author":"AJ Lowery","year":"2012","unstructured":"Lowery AJ, Kell MR, Glynn RW, Kerin MJ, Sweeney KJ (2012) Locoregional recurrence after breast cancer surgery: a systematic review by receptor phenotype. Breast Cancer Res Treat 133(3):831\u2013841. https:\/\/doi.org\/10.1007\/s10549-011-1891-6","journal-title":"Breast Cancer Res Treat"},{"issue":"3","key":"8049_CR25","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1007\/s10549-025-07804-5","volume":"214","author":"L Nolan","year":"2025","unstructured":"Nolan L, Huan H, McDonnell W, Walsh S, Lowery A (2025) The impact of mammographic breast density on locoregional recurrence in breast cancer: a systematic review and meta-analysis. Breast Cancer Res Treat 214(3):289\u2013302. https:\/\/doi.org\/10.1007\/s10549-025-07804-5","journal-title":"Breast Cancer Res Treat"},{"issue":"9804","key":"8049_CR26","doi-asserted-by":"publisher","first-page":"1707","DOI":"10.1016\/S0140-6736(11)61629-2","volume":"378","author":"S Darby","year":"2011","unstructured":"Early Breast Cancer Trialists\u2019 Collaborative Group (EBCTCG), Darby S, McGale P, Correa C, Taylor C, Arriagada R et al (2011) Effect of radiotherapy after breast-conserving surgery on 10-year recurrence and 15-year breast cancer death: meta-analysis of individual patient data for 10,801 women in 17 randomised trials. Lancet 378(9804):1707\u20131716. https:\/\/doi.org\/10.1016\/S0140-6736(11)61629-2","journal-title":"Lancet"},{"issue":"17","key":"8049_CR27","doi-asserted-by":"publisher","first-page":"4371","DOI":"10.3390\/cancers13174371","volume":"13","author":"YC Cheung","year":"2021","unstructured":"Cheung YC, Chen K, Yu CC, Ueng SH, Li CW, Chen SC (2021) Contrast-Enhanced Mammographic Features of In Situ and Invasive Ductal Carcinoma Manifesting Microcalcifications Only: Help to Predict Underestimation? Cancers (Basel) 13(17):4371. https:\/\/doi.org\/10.3390\/cancers13174371","journal-title":"Cancers (Basel)"},{"key":"8049_CR28","first-page":"1","volume":"1970","author":"B Fisher","year":"1970","unstructured":"Fisher B (1970) The surgical dilemma in the primary therapy of invasive breast cancer: a critical appraisal. Curr Probl Surg 1970:1\u201353","journal-title":"Curr Probl Surg"},{"key":"8049_CR29","doi-asserted-by":"publisher","first-page":"10007","DOI":"10.1158\/0008-5472.CAN-08-0186","volume":"68","author":"B Fisher","year":"2008","unstructured":"Fisher B (2008) Biological research in the evolution of cancer surgery: a personal perspective. Cancer Res 68:10007\u201310020. https:\/\/doi.org\/10.1158\/0008-5472.CAN-08-0186","journal-title":"Cancer Res"},{"issue":"9938","key":"8049_CR30","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1016\/S0140-6736(13)62422-8","volume":"384","author":"P Cortazar","year":"2014","unstructured":"Cortazar P, Zhang L, Untch M, Mehta K, Costantino JP et al (2014) Pathological complete response and long-term clinical benefit in breast cancer: the CTNeoBC pooled analysis. Lancet 384(9938):164\u2013172. https:\/\/doi.org\/10.1016\/S0140-6736(13)62422-8","journal-title":"Lancet"},{"issue":"12","key":"8049_CR31","doi-asserted-by":"publisher","first-page":"2838","DOI":"10.1158\/1078-0432.CCR-19-3492","volume":"26","author":"LM Spring","year":"2020","unstructured":"Spring LM, Fell G, Arfe A, Sharma C, Greenup R et al (2020) Pathologic Complete Response after Neoadjuvant Chemotherapy and Impact on Breast Cancer Recurrence and Survival: A Comprehensive Meta-analysis. Clin Cancer Res 26(12):2838\u20132848. https:\/\/doi.org\/10.1158\/1078-0432.CCR-19-3492","journal-title":"Clin Cancer Res"},{"issue":"5","key":"8049_CR32","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1200\/JCO.18.01160","volume":"37","author":"HJ Burstein","year":"2019","unstructured":"Burstein HJ, Lacchetti C, Anderson H, Buchholz TA, Davidson NE et al (2019) Adjuvant Endocrine Therapy for Women With Hormone Receptor-Positive Breast Cancer: ASCO Clinical Practice Guideline Focused Update. J Clin Oncol 37(5):423\u2013438. https:\/\/doi.org\/10.1200\/JCO.18.01160","journal-title":"J Clin Oncol"},{"issue":"19","key":"8049_CR33","doi-asserted-by":"publisher","first-page":"1836","DOI":"10.1056\/NEJMoa1701830","volume":"377","author":"H Pan","year":"2017","unstructured":"Pan H, Gray R, Braybrooke J, Davies C, Taylor C et al (2017) EBCTCG. 20-Year Risks of Breast-Cancer Recurrence after Stopping Endocrine Therapy at 5 Years. N Engl J Med 377(19):1836\u20131846. https:\/\/doi.org\/10.1056\/NEJMoa1701830","journal-title":"N Engl J Med"},{"key":"8049_CR34","doi-asserted-by":"publisher","unstructured":"Early Breast Cancer Trialists\u2019 Collaborative Group (EBCTCG) (2005 May) Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival: an overview of the randomised trials. Lancet 94721687\u20131717 14\u201320;365. https:\/\/doi.org\/10.1016\/S0140-6736(05)66544-0","DOI":"10.1016\/S0140-6736(05)66544-0"},{"issue":"10423","key":"8049_CR35","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1016\/S0140-6736(23)02476-5","volume":"403","author":"GB Mann","year":"2024","unstructured":"Mann GB, Skandarajah AR, Zdenkowski N, Hughes J, Park A et al (2024) Postoperative radiotherapy omission in selected patients with early breast cancer following preoperative breast MRI (PROSPECT): primary results of a prospective two-arm study. Lancet 403(10423):261\u2013270. https:\/\/doi.org\/10.1016\/S0140-6736(23)02476-5","journal-title":"Lancet"},{"issue":"9","key":"8049_CR36","first-page":"917","volume":"9","author":"CK Chow","year":"2000","unstructured":"Chow CK, Venzon D, Jones EC, Premkumar A, O\u2019Shaughnessy J et al (2000) Effect of tamoxifen on mammographic density. Cancer Epidemiol Biomarkers Prev 9(9):917\u2013921","journal-title":"Cancer Epidemiol Biomarkers Prev"}],"container-title":["Breast Cancer Research and Treatment"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10549-026-08049-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10549-026-08049-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10549-026-08049-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,25]],"date-time":"2026-08-25T06:49:03Z","timestamp":1787640543000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10549-026-08049-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8]]},"references-count":36,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2026,8]]}},"alternative-id":["8049"],"URL":"https:\/\/doi.org\/10.1007\/s10549-026-08049-6","relation":{},"ISSN":["0167-6806","1573-7217"],"issn-type":[{"value":"0167-6806","type":"print"},{"value":"1573-7217","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8]]},"assertion":[{"value":"26 May 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 July 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 August 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This study was performed in line with the principles of the Declaration of Helsinki. The project was approved by the Melbourne Health Research and Ethics Committee as a Quality Assurance project (QA2019129).","order":1,"name":"Ethics","label":"Ethical approval","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Author GBM has received research support from Hologic. Author AKR has served once on an advisory board for Hologic. All other authors declare no relevant financial or non-financial interests to disclose.","order":2,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"45"}}